WallStSmart

Marex Group plc Ordinary Shares (MRX)vsMorgan Stanley (MS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Morgan Stanley generates 2140% more annual revenue ($73.17B vs $3.27B). MS leads profitability with a 24.7% profit margin vs 10.6%. MRX trades at a lower P/E of 14.1x. MS earns a higher WallStSmart Score of 71/100 (B).

MRX

Strong Buy

68

out of 100

Grade: B-

Growth: 10.0Profit: 6.5Value: 6.0Quality: 3.8
Piotroski: 3/9Altman Z: 0.86

MS

Strong Buy

71

out of 100

Grade: B

Growth: 9.3Profit: 7.5Value: 4.3Quality: 4.0
Piotroski: 5/9Altman Z: 0.38

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MRX4 strengths · Avg: 9.3/10
Revenue GrowthGrowth
55.1%10/10

Revenue surging 55.1% year-over-year

EPS GrowthGrowth
55.4%10/10

Earnings expanding 55.4% YoY

Return on EquityProfitability
29.1%9/10

Every $100 of equity generates 29 in profit

P/E RatioValuation
14.1x8/10

Attractively priced relative to earnings

MS5 strengths · Avg: 9.0/10
Market CapQuality
$339.08B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
40.6%10/10

Strong operational efficiency at 40.6%

Profit MarginProfitability
24.7%9/10

Keeps 25 of every $100 in revenue as profit

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

EPS GrowthGrowth
31.9%8/10

Earnings expanding 31.9% YoY

Areas to Watch

MRX2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
0.862/10

Distress zone — elevated risk

MS4 concerns · Avg: 1.8/10
PEG RatioValuation
2.542/10

Expensive relative to growth rate

Free Cash FlowQuality
$-7.85B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

Debt/EquityHealth
3.451/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MRX

The strongest argument for MRX centers on Revenue Growth, EPS Growth, Return on Equity. Revenue growth of 55.1% demonstrates continued momentum.

Bull Case : MS

The strongest argument for MS centers on Market Cap, Operating Margin, Profit Margin. Profitability is solid with margins at 24.7% and operating margin at 40.6%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : MRX

The primary concerns for MRX are Piotroski F-Score, Altman Z-Score.

Bear Case : MS

The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 3.45 is elevated, increasing financial risk.

Key Dynamics to Monitor

MS carries more volatility with a beta of 1.21 — expect wider price swings.

MRX is growing revenue faster at 55.1% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MS scores higher overall (71/100 vs 68/100), backed by strong 24.7% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Marex Group plc Ordinary Shares

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Marex Group plc is a leading global commodities brokerage and risk management firm that offers comprehensive trading, clearing, and advisory services across vital sectors, including metals, energy, and agricultural commodities. Leveraging cutting-edge technology and extensive market expertise, Marex delivers tailored solutions to a wide range of clients, from multinational corporations to financial institutions and hedge funds. As a publicly traded company, Marex is committed to operational excellence and strategic growth, aiming to strengthen its competitive position in the commodities trading sector while generating sustainable value for its shareholders.

Morgan Stanley

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.

Want to dig deeper into these stocks?